Stefano Taddei

Author PubWeight™ 111.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension 2013 2.82
2 The assessment of endothelial function: from research into clinical practice. Circulation 2012 2.68
3 Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.46
4 Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.12
5 Relationship between wave reflection and renal damage in hypertensive patients: a retrospective analysis. J Hypertens 2013 1.98
6 Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens 2015 1.97
7 Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009 1.91
8 Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. Eur Heart J 2012 1.91
9 Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol 2009 1.81
10 Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 2010 1.67
11 Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens 2012 1.62
12 Endothelium-dependent contractions in hypertension. Br J Pharmacol 2005 1.59
13 Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 2003 1.49
14 Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005 1.49
15 Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press 2005 1.49
16 Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation 2009 1.49
17 Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003 1.48
18 A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004 1.40
19 Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up. Nephrol Dial Transplant 2011 1.40
20 Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension 2008 1.39
21 Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007 1.36
22 The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 2003 1.33
23 Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009 1.27
24 The eye and the heart. Eur Heart J 2013 1.18
25 Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 2004 1.17
26 Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011 1.16
27 Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2010 1.11
28 Sympathetic regulation of vascular function in health and disease. Front Physiol 2012 1.07
29 Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol 2012 1.06
30 Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis. Free Radic Biol Med 2010 1.02
31 Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2006 1.02
32 Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. Hypertension 2010 0.97
33 Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. Int J Hypertens 2011 0.96
34 Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 2007 0.96
35 Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 2009 0.96
36 Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006 0.95
37 Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 2008 0.94
38 Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort. J Hypertens 2008 0.93
39 Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc Ultrasound 2014 0.92
40 Poor sleep quality and resistant hypertension. Sleep Med 2013 0.91
41 Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. J Hypertens 2013 0.90
42 Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation. Curr Med Res Opin 2010 0.90
43 Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep 2011 0.89
44 Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 2004 0.88
45 Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2007 0.88
46 Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc Diabetol 2012 0.88
47 Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 2006 0.88
48 Local carotid stiffness and intima-media thickness assessment by a novel ultrasound-based system in essential hypertension. Atherosclerosis 2012 0.87
49 Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens 2011 0.87
50 Human endothelial dysfunction: EDCFs. Pflugers Arch 2010 0.86
51 Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002 0.86
52 Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol 2011 0.86
53 Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst 2013 0.86
54 Inflammation and not cardiovascular risk factors is associated with short leukocyte telomere length in 13- to 16-year-old adolescents. Arterioscler Thromb Vasc Biol 2012 0.86
55 The ageing endothelium, cardiovascular risk and disease in man. Exp Physiol 2008 0.85
56 Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. Am J Cardiol 2010 0.85
57 Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension. Curr Hypertens Rep 2009 0.84
58 Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension? J Nephrol 2002 0.84
59 Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study. Cardiovasc Ultrasound 2014 0.84
60 Functional and structural alterations of large arteries: methodological issues. Curr Pharm Des 2013 0.83
61 Phosphodiesterase 5 inhibition in essential hypertension. Curr Hypertens Rep 2008 0.83
62 Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med 2009 0.83
63 Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection? Eur Heart J 2012 0.83
64 Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients. Am J Clin Nutr 2012 0.82
65 Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats. Endocrinology 2008 0.82
66 Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J 2012 0.82
67 Coronary flow reserve in idiopathic dilated cardiomyopathy: relation with left ventricular wall stress, natriuretic peptides, and endothelial dysfunction. J Am Soc Echocardiogr 2009 0.82
68 Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension 2006 0.82
69 Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis 2013 0.82
70 Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). Trials 2013 0.82
71 Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 2008 0.81
72 The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment. J Clin Endocrinol Metab 2009 0.80
73 Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects. Atherosclerosis 2005 0.80
74 Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study. Clin Drug Investig 2010 0.80
75 Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant. Clin Endocrinol (Oxf) 2008 0.80
76 Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS One 2013 0.80
77 Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication. Blood Press 2008 0.79
78 Association between short leukocyte telomere length, endotoxemia, and severe periodontitis in people with diabetes: a cross-sectional survey. Diabetes Care 2014 0.79
79 Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009 0.79
80 Psychological predictors of the antihypertensive effects of music-guided slow breathing. J Hypertens 2010 0.79
81 Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur Heart J 2011 0.79
82 Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. Biomed Pharmacother 2009 0.78
83 Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension 2007 0.78
84 Evaluation of microvascular structure in humans: a 'state-of-the-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens 2014 0.78
85 Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol Dial Transplant 2006 0.78
86 Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. High Blood Press Cardiovasc Prev 2014 0.78
87 Microvascular endothelial dysfunction in obesity and hypertension. Curr Pharm Des 2013 0.77
88 Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003 0.77
89 Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1. Br J Pharmacol 2013 0.77
90 Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it. Eur J Cardiovasc Prev Rehabil 2009 0.77
91 Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis 2008 0.77
92 Birth weight and arterial hypertension. Curr Opin Cardiol 2015 0.77
93 P2X7 receptor polymorphisms do not influence endothelial function and vascular tone in neo-diagnosed, treatment-naive essential hypertensive patients. J Hypertens 2013 0.77
94 Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story? Hypertension 2006 0.76
95 Hypertension in special populations: athletes. Future Cardiol 2011 0.76
96 Exogenous ghrelin on nitric oxide-endothelin 1 imbalance in metabolic syndrome: can we kill 2 birds with 1 stone? Hypertension 2009 0.76
97 Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil. J Androl 2004 0.76
98 Human Ghrelin: A Gastric Hormone with Cardiovascular Properties. Curr Pharm Des 2015 0.76
99 Sporadic or familial head neck paragangliomas enrolled in a single center: clinical presentation and genotype/phenotype correlations. Head Neck 2012 0.76
100 Endothelial function in hypertension: role of gender. J Hypertens Suppl 2002 0.76
101 At the beginning of stiffening: endothelial dysfunction meets "pulsology". Hypertension 2006 0.75
102 Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial. J Hypertens 2012 0.75
103 How to evaluate microvascular organ damage in hypertension: assessment of endothelial function. High Blood Press Cardiovasc Prev 2011 0.75
104 Angiotensin II as the link between nitric oxide and neuroadrenergic function. J Hypertens 2005 0.75
105 Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? Hypertension 2013 0.75
106 Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study. J Hypertens 2016 0.75
107 Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas. Clin Nucl Med 2014 0.75
108 Long life to olive oil and wine! Long life with olive oil and wine? J Hypertens 2008 0.75
109 Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. J Hypertens 2016 0.75
110 Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants. Curr Pharm Des 2014 0.75
111 Clinical management of drug-induced hypertension: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev 2014 0.75
112 Understanding the relationship between lung function and cardiovascular phenotypes in the young: opportunity for a better cardiovascular risk prevention in adulthood? J Hypertens 2017 0.75
113 Multigroup confirmatory factor analysis of U.S. and Italian children's performance on the PASS theory of intelligence as measured by the Cognitive Assessment System. Psychol Assess 2012 0.75
114 Adrenal hormones and the heart. Eur Heart J 2015 0.75
115 [The HEAAL study]. G Ital Cardiol (Rome) 2010 0.75
116 Blood pressure and vascular alterations with growth in childhood. Curr Pharm Des 2011 0.75
117 Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study. J Hypertens 2016 0.75
118 [The Symplicity HTN-3 study]. G Ital Cardiol (Rome) 2014 0.75
119 Device-based therapies for resistant hypertension. Curr Pharm Des 2013 0.75
120 Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects. J Hypertens 2006 0.75
121 [Resistant hypertension: a case report]. Recenti Prog Med 2010 0.75
122 Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction. Eur Heart J 2017 0.75
123 Endothelial Dysfunction in Resistance Arteries of Hypertensive Humans: Old and New Conspirators. J Cardiovasc Pharmacol 2016 0.75